EducateNext: The Global Impact of the PRECEDE Consortium

Description

In this presentation, the current status of pancreatic incidence and mortality will be reviewed. The impact of germline testing on understanding pancreatic cancer risk will be discussed, along with the following areas of research advances: Biomarker testing, AI and imaging, Identification of missing heritability using long read sequencing and Multi-modal data integration for risk calculation.

 

Level of Instruction
Intermediate - Refresher course; some basic knowledge of subject recommended
 

Learning Objectives

1. Describe the current status of pancreatic cancer incidence and mortality in the US.
2. Discuss the impact of germline genetic testing on understanding pancreatic cancer risk, and the role of long read sequencing in advancing knowledge about heritability of pancreatic cancer.
3. Describe the role of imaging and biomarker testing in pancreatic cancer early detection.

 

 

Course summary

Available credit: 
  • 0.10 NSGC CEU
Course opens: 
09/17/2026
Course expires: 
09/17/2028
Cost:
$0.00

Presenter: Diane Simeone, MD

Director of Moores Cancer Center at UC San Diego Health

Diane Simeone, MD, is Director of Moores Cancer Center at UC San Diego Health and holds the Koman Family Presidential Director’s Chair. An internationally recognized pancreatic surgeon-scientist, she leads the Cancer Center’s research, clinical, and strategic initiatives and serves as principal investigator of its National Cancer Institute Cancer Center Support Grant. Dr. Simeone is a national leader in pancreatic cancer research and clinical innovation, serving as principal investigator of Precision Promise, a groundbreaking clinical trials consortium, and founding the Pancreatic Cancer Early Detection Consortium. A member of the National Academy of Medicine, she has held numerous leadership roles in oncology and surgery and is dedicated to advancing early detection and more effective treatments for pancreatic cancer.

 

Moderator: Amanda Jacquart, MS, CGC

Genomic Science Liaison at Ambry Genetics

Amanda is a Genomic Science Liaison at Ambry Genetics, where her work focuses on providing clinical and technical genetic testing education to healthcare providers across the Midwest. She earned her MS in Genetic Counseling from the University of Pittsburgh and is certified by the American Board of Genetic Counseling. Prior to joining Ambry, she practiced as a clinical genetic counselor at the Froedtert & MCW Clinical Cancer Center. Amanda also mentors future counselors as Adjunct Faculty at the Medical College of Wisconsin and previously served as President of the Wisconsin Genetic Counselors Association.


Educational Independence and Disclosure Policy

EducateNext is committed to providing independent, objective, and evidence-based educational content. None of the individuals in control of this content—including our planners, reviewers, and approval faculty—have any financial relationships with ineligible companies to disclose. For all educational sessions, speaker-specific disclosures regarding any potential conflicts of interest are required and will always be shared directly with learners at the beginning of their respective presentations.

Ambry Genetics is an approved provider of continuing education through the NSGC and ASCLS P.A.C.E.® programs. Credit eligibility varies by activity; please see below for the specific credit types offered for this course.

 

Available Credit

  • 0.10 NSGC CEU

Price

Cost:
$0.00
Please login or register to take this course.
  • Click above to register for and complete this activity.
  • You can review your pending and completed registrations at any time by going to My Account > My Activities.

Please note: Attendees must track continuing education (CE) credits towards recertification. Credit cannot be claimed for both live and recorded versions of the same webinar; attendance is cross-checked annually. We apologize for the inconvenience and are working toward a single-platform solution to automatically manage dual registration and integrated transcript tracking.